Home » Stocks » GH

Guardant Health, Inc. (GH)

Stock Price: $161.64 USD -1.71 (-1.04%)
Updated Jan 21, 2021 12:34 PM EST - Market open
Market Cap 16.33B
Revenue (ttm) 271.31M
Net Income (ttm) -185.25M
Shares Out 99.55M
EPS (ttm) -1.93
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 21
Last Price $161.64
Previous Close $163.34
Change ($) -1.71
Change (%) -1.04%
Day's Open 164.00
Day's Range 159.55 - 164.93
Day's Volume 361,808
52-Week Range 59.04 - 164.93

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 3 days ago

BARCELONA, Spain & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Vall d'Hebron Institute of Oncology (VHIO), one of Europ...

Business Wire - 1 week ago

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), along with leading academic institutions and pharmaceutical companies, will present data highlighting the clinical ut...

The Motley Fool - 1 week ago

And they could do it sooner rather than later.

Other stocks mentioned: CRLBF, FVRR
Business Wire - 3 weeks ago

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming 39th Annual J...

24/7 Wall Street - 3 weeks ago

As is the case every year, the major Wall Street firms we cover here at 24/7 Wall St.

Other stocks mentioned: AVTR, HCA, HOLX, CTLT
The Motley Fool - 3 weeks ago

All three could be huge winners in the new year -- and over the long run.

Other stocks mentioned: ISRG, VRTX
The Motley Fool - 1 month ago

All three have already made investors a lot of money this year.

Other stocks mentioned: MDB, TRUP
Business Wire - 1 month ago

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company's new Chief Financial Officer (CFO) effec...

Business Wire - 1 month ago

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, shares new data at the 2020 Virtual San Antonio Breast Cancer Symposium (SABCS)...

The Motley Fool - 1 month ago

All three are already big winners this year. Even better days could be in store.

Other stocks mentioned: MDB, TTD
Seeking Alpha - 2 months ago

As COVID-19 decelerates its growth, Guardant has failed to generate sizable capital gains despite the recent FDA signoff. With vaccine hopes rising, the consensus revenue estimates look overly...

Seeking Alpha - 2 months ago

Multiple companies are working on next-gen blood biopsies tech to detect cancer. The potential market size is big according to most estimates and analysts.

Other stocks mentioned: EXAS, ILMN, NTRA, PSNL
Business Wire - 2 months ago

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior note...

The Motley Fool - 2 months ago

Hint: The diagnostics company's balance sheet is going to record some big changes quite soon.

Business Wire - 2 months ago

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amo...

The Motley Fool - 2 months ago

These two diagnostics companies are trying to cash in on demand for coronavirus tests.

Other stocks mentioned: QDEL
Seeking Alpha - 2 months ago

Guardant Health, Inc. (GH) CEO Helmy Eltoukhy on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Guardant Health (GH) delivered earnings and revenue surprises of -129.41% and 12.18%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the s...

Business Wire - 2 months ago

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood ...

Zacks Investment Research - 2 months ago

Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CNN Business - 3 months ago

Big Tech companies have been the hottest stocks on Wall Street all year, pre- and post-pandemic. But some experts think it's time for a new crop of dynamic up-and-comers in fields like virtual...

Other stocks mentioned: CRWD, DDOG, OKTA, SDGR, U, ZS
The Motley Fool - 3 months ago

The company is chasing a massive opportunity, but growth slowed this year.

Business Wire - 3 months ago

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5...

Business Wire - 3 months ago

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH) (“Guardant Health”), a leading precision oncology company focused on helping conquer cancer globally through use of it...

The Motley Fool - 3 months ago

Disruptive companies with a smaller market cap can be a key component to achieving a seven-figure nest egg.

Other stocks mentioned: MDB, OKTA
The Motley Fool - 3 months ago

These companies are likely to be a lot bigger in 2040 -- and make patient investors a ton of money along the way.

Other stocks mentioned: ISRG, SE
The Motley Fool - 3 months ago

Softbank is offering shares of the precision oncology company at a (temporary) bargain price.

Business Wire - 3 months ago

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH) (“Guardant Health”), a leading precision oncology company focused on helping conquer cancer globally through use of it...

Business Wire - 3 months ago

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH) (“Guardant Health”), a leading precision oncology company focused on helping conquer cancer globally through use of it...

Business Wire - 3 months ago

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH). Despite advances in precision oncology, progress is slowed by the limitations of tissue genotyping, which is traditio...

Zacks Investment Research - 3 months ago

COVID-19 has created an Apollo Mission status for advanced medical technologies and smart investors are profiting.

Other stocks mentioned: BDX, EXAS, ILMN, NTRA, NVTA, QDEL
Investopedia - 3 months ago

Bullish charts across the healthcare services subsector suggest that this niche segment could be the one to watch over the months ahead.

Other stocks mentioned: OMI, XHS
The Motley Fool - 3 months ago

This company's diagnostic blood tests made it a hot IPO two years ago, but competitors are catching up, and COVID-19 could derail its critical study.

The Motley Fool - 4 months ago

They're all innovative disruptors, but these three stocks could outperform Tesla over the next decade.

Other stocks mentioned: IIPR, MDB
Seeking Alpha - 4 months ago

Guardant Health: High Price But Lots Of Potential

The Motley Fool - 4 months ago

Sure, Tesla stock has been on fire this year. But these three stocks could be bigger winners over the long run.

Other stocks mentioned: LVGO, SQ
GlobeNewsWire - 4 months ago

REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcar...

The Motley Fool - 4 months ago

Sometimes the best place to look for a stock that could double is checking out the ones that already have.

Other stocks mentioned: ROKU, TEAM
Investors Business Daily - 4 months ago

Intuitive Surgical, Edwards Lifesciences, Boston Scientific, Novocure and Guardant Health are top medical stocks that may thrive as coronavirus cases fall.

Other stocks mentioned: EW, ISRG, BSX, NVCR
The Motley Fool - 4 months ago

You don't need a huge initial investment with massive growth opportunities from these stocks.

Other stocks mentioned: FSLY, NVAX
The Motley Fool - 4 months ago

If you won't need that $1,200 to pay your immediate bills, why not use it to bolster your long-term financial plan?

Other stocks mentioned: AMD, SE
Investors Business Daily - 4 months ago

Guardant Health on Monday announced that the U.S. Food and Drug Administration granted emergency use authorization for its Covid-19 test.

GlobeNewsWire - 4 months ago

COVID-19 diagnostic expands testing supply, protects the continuity of essential cancer work at Guardant Health, and helps with reopening at Delaware State University COVID-19 diagnostic expan...

GlobeNewsWire - 5 months ago

REDWOOD CITY, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the following investor virtual conferences.

Seeking Alpha - 5 months ago

Guardant Health, Inc. (GH) CEO Helmy Eltoukhy on Q2 2020 - Earnings Call Transcript

PRNewsWire - 5 months ago

SINGAPORE, Aug. 7, 2020 /PRNewswire/ -- The U.S.

GlobeNewsWire - 5 months ago

Now FDA approved, the Guardant360 CDx delivers critical genomic information to oncologists from a simple blood draw Now FDA approved, the Guardant360 CDx delivers critical genomic information ...

The Motley Fool - 5 months ago

The liquid biopsy company beat revenue estimates in Q2, but its bottom line fell short of expectations.

Zacks Investment Research - 5 months ago

Guardant Health (GH) delivered earnings and revenue surprises of -42.50% and 10.86%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 5 months ago

Q2 2020 Revenue Increase of 23% Over Prior Year Period

About GH

Guardant Health, a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer su... [Read more...]

Industry
Diagnostics & Research
IPO Date
Oct 4, 2018
Stock Exchange
NASDAQ
Ticker Symbol
GH
Full Company Profile

Financial Performance

In 2019, GH's revenue was $214.38 million, an increase of 136.52% compared to the previous year's $90.64 million. Losses were -$75.65 million, -11.06% less than in 2018.

Financial Statements

Analyst Forecasts

According to 11 analysts, the average rating for GH stock is "Strong Buy." The 12-month stock price forecast is 151.89, which is a decrease of -6.03% from the latest price.

Price Target
$151.89
(-6.03% downside)
Analyst Consensus: Strong Buy